Aim-To compare the immunoreactivity of monoclonal antibodies S12 and CS1-4, which recognise different epitopes of the Epstein-Barr virus (EBV) latent membrane protein-I (LMP-1), in EBV associated benign and malignant lymphoproliferative disorders and control tissues processed using different methods. Results-Both monoclonal antibodies gave comparable results on frozen tissue sections and formalin fixed, paraffin wax embedded samples from cases with Hodgkin's disease and infectious mononucleosis. In all cases S12 stained more cells than CS1-4. For EBV associated B and T non-Hodgkin's lymphomas, frozen tissue sections yielded better LMP-I staining results than formalin fixed material. Again, in all these cases S12 stained more cells and gave stronger results than CS1-4. For EBV negative tissues, both monoclonal antibodies showed cross-reactivity with melanocytic-like cells in the basal cell layer of the skin, synaptophysin-like staining in layers three and four of the cortex of the brain, and myelin-like staining in peripheral nerves and peripheral ganglion cells. Staining with S12 was always much stronger. Moreover, in contrast to CSI-4, S12 stained pancreatic islands in formalin fixed material but not in frozen tissue sections and sporadically stained solitary epithelial cells in the large bowel especially in formalin fixed tissue sections. CS1-4 also cross-reacted with myoepithelial cells around hair follicles and other adnexa of the skin. Conclusion-The results indicate that for optimal detection of LMP-1, S12 yields better results than CS1-4 and that tissue processing is very important especially when B and T non-Hodgkin's lymphomas are examined. ( Clin Pathol 1995;48:438-442) 
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Methods
The only tissues used in this study were those which harboured EBV DNA sequences as detected by the polymerase chain reaction (PCR) using primers selected from the large internal repeat of the B95-8 strain and which showed diffuse staining on RNA in situ hybridisation using EBER-1 and -2 probes. The EBV DNA PCR and the RNA in situ hybridisation procedures have been described in detail elsewhere. 4818 Five different groups of EBV associated lymphoproliferative disorders were included in this study: (1) tonsil tissue samples from four patients with serological and clinical evidence of infectious mononucleosis; (2) lymph nodes from five patients with Hodgkin's disease; (3) lymph nodes, large intestine, pancreas, liver, adrenal gland, and kidney involved in B immunoblastic lymphoma from four bone marrow transplant recipients; (4) three lymph nodes involved in B cell non-Hodgkin's lymphoma and three lymph nodes involved in T cell nonHodgkin's lymphoma from six immunocompetent patients. Three non-malignant lymph nodes which reacted positively in the EBV DNA PCR and in which sporadic EBER-1 and -2 positive cells were detected were also included in this study.
The following non-malignant tissue samples were used: tonsil, hyperplastic lymph nodes, spleen, thymus, appendix, small and large intestine, stomach, liver, pancreas, lung, urinary bladder, kidney, prostate, thyroid, adrenal gland, pituitary gland, skin, testis, ovary and brain, and peripheral nerves.
On the basis of the reactivity with non-malignant tissue, histiocytosis X, insulinoma, and cutaneous melanoma tissue samples were also investigated. IMMUNOHISTOCHEMISTRY S12 (OT17) lgG2a monoclonal antibody was obtained from Organon Teknika (Boxtel, The Netherlands). S12 was produced in a serum free hollow fibre cell culture system and subsequently purified over a protein A column. For immunohistochemistry, a final concentration of 0-1 ,ug/ml was used. S12 was detected using biotinylated horse antimouse lgG (diluted 1 in 250; Vector, Burlingame, California, USA), followed by Streptavidin-horseradish peroxidase (HRP) (diluted 1 in 500; Dako, Glostrup, Denmark) and visualised by diaminobenzidine (DAB; Sigma, St Louis, Missouri, USA) or amine-ethylcarbazole (AEC; Sigma) with 0-02% H202 in phosphate buffered saline (PBS) (pH 7-4). Alternatively, S12 was detected using goat antimouselgG2a and HRP (diluted 1 in 100; Southern Biotechnology Ass., Birmingham, UK) and directly visualised using DAB or AEC with 0-02% H202. 1) . The pancreatic islets showed strong reactivity when formalin fixed, paraffin wax embedded material was used. Frozen tissue sections fixed with (para)formaldehyde also showed similar reactivity. No staining of the pancreatic islets was observed when the frozen tissue sections were fixed in acetone or methanol. Otherwise, results were independent of fixation. CS 1-4 also reacted with the basal cells in the epidermis ofnormal skin, but cross-reactivity in normal brain and peripheral nerve tissue was also observed. Staining with S12 was always much stronger. Moreover, in contrast to S12, myoepithelial cells and smooth muscle cells also showed faint cross-reactivity; no crossreactivity with pancreatic islets was observed.
DETECTION OF LMP-1 IN EBV ASSOCIATED LYMPHOPROLIFERATIVE DISEASES
In EBV positive Hodgkin's disease both monoclonal antibodies stained H-RS cells (fig 2) . Both formalin fixed, paraffin wax embedded and frozen tissue sections could be used. Besides the typical H-RS cells, S12 also stained a large number of "intermediate sized" cells (resembling an atypical blastoid morphology) and also a considerable number of small, morphologically non-malignant lymphoid cells. These smaller cells were only observed sporadically when CS 1-4 was used. Double staining with S12 (lgG2a) and CS1-4 (lgGl) revealed that large atypical cells frequently showed "true" double staining (3A). Smaller cells reacted exclusively with S12 (figs 3B and 3C), whereas S12 negative/CS 1-4 positive intermediate sized and small cells were never observed. Using EBER-1 and -2 probes in combination with S12 and CS1-4, the H-RS cells frequently showed staining for both the EBER-1 and -2 RNA and LMP-1 protein. This co-expression was also observed in a substantial number of the smaller EBER-1 and -2 positive cells (fig 4) , but only when S12 was used. In all cases of EBV positive Hodgkin's disease a considerable number of EBER-1 and -2 positive large, intermediate and small cells could be visualised without any LMP-1 being detected. These EBER positive/LMP-1 negative cells were present more frequently in tissue sections stained with CS1-4 than with S12.
In infectious mononucleosis and in the different EBV positive B and T non-Hodgkin's lymphoma cell sections the staining pattern was different. In all of these cases most of the EBER-1 and -2 positive cells were LMP-1 negative ( fig 5) . Frozen tissue sections fixed with 4% (para)formaldehyde, methanol or acetone showed much more positive cells compared with formalin fixed, paraffin wax embedded material. Again, S 12 positive cells outnumbered the CS 1-4 positive cells.
Finally, blocking experiments were performed to investigate whether S12 and CS 1-4 recognise different epitopes. Pre-incubation with a tenfold excess of CS 1-4 was unable to prevent specific binding of S 12 and vice versa, indicating that, at least in part, different epitopes of the LMP-1 molecule were detected.
Discussion
The results of this study show that S12 has certain advantages over CS 1-4 when EBV associated lymphoproliferative disorders were investigated for the expression of LMP-1; in EBV associated B and T cell non-Hodgkin's lymphoma more cells were stained and the signals were moderately stronger. The number of EBER-1/2 positive neoplastic cells outnumbered the LMP-1 positive cells in all cases. This indicates that despite the clonal character of these tumours, there is variability in EBV gene expression, particularly of LMP-1. This was also true for infectious mononucleosis where only some of the EBER-1 and -2 positive cells expressed detectable LMP-1. Although in Hodgkin's disease both S12 and CS1-4 could be used on formalin fixed, paraffin wax embedded material or frozen tissue sections, S12 stained more H-RS cells and also more smaller EBER-1 and -2 positive cells as observed using double staining techniques for EBER-1 and -2 messenger RNAs and immunohistochemistry for LMP-1 detection.
In previous studies CS3 and CS4 crossreacted in immunoblots with certain cellular proteins of a molecular weight of 41 kDa and 44 kDa. " Although cross-reactivity was never observed on EBV negative/control lymphoid tissue, S12 has a slightly different reactivity pattern on normal human tissues than CS 1-4.
These differences are remarkable as both sets of monoclonal antibodies are directed against the same 46 kDa fusion protein. 14 15Our data on double staining using both anti-LMP-1 antibodies and the observation that pre-incubation with S 12 or CS 1-4 could not prevent specific binding of the other anti-LMP-1 antibody confirm that different epitopes are detected. Similar results were observed in immunoblots: pre-incubation with CS 1-4 was unable to prevent specific binding of S12 and vice versa (data not shown). The fact that the staining pattern of S12 in EBV infected cells was slightly different from that of CS1-4 suggests that the epitope of S12 is differentially Figure 1 Formalin fixed, paraffin wax embedded tissue sections of normal pancreas stained with S12. Note the non-specific staining of the pancreatic islets by S12. Jisualisation using DAB/H202 (brown); original magnification x 300. Figure 2 A: Lymph node with Hodgkin s disease. Large atypical cells reacted with S12. Visualisation using AECIH202 (red); original magnification x 520. B: The same lymph node stained with CS1-4. Visualisation using alkaline phosphatase (blue); original magnification x 520. Figure 3 A: Double staining with S12 and CS1-4. S12 (lgG2a) was detected using a subclass specific antibody and was visualised with AEC/IH202. Staining with CS1-4 (7gG1) was visualised using alkaline phosphatase (blue Figure 4 Combination between RNA in situ hybridisation using EBER-1 and -2 RNA probes (visualisation using DABI-Ni/H202 with silver enchancement; black grains) and LMP-1 detected by S12 (DABIH202; brown). Note that not only are the large atypical cells stained with both, but also the morphologically "non-malignant" lymphoid cells (arrowhead). Original magnification x 825. Figure 5 Immunoblastic B cell non-Hodgkin s lymphoma in a bone marrow transplant recipient stained with S12. VKsualisation using AECIH202 . In this regard, it is important to note that LMP-1 in its nascent form has a very short halflife oftwo to five hours in vitro, is processed differently at the posttranslational level and sub-fragments may localise to different cellular compartments. 9 20 The clinical importance ofLMP-1 expression in the different lymphoma groups is still obscure. It is known that EBV is more frequently present in more aggressive forms of Hodgkin's disease for example, the mixed cellularity type, whereas no differences in clinical behaviour have been reported between EBV positive and negative cases.2' In non-Hodgkin's lymphoma little is known about the clinical importance of EBV infection. In one study of nodal T cell non-Hodgkin's lymphoma cases diffusely positive for EBER-1 and -2 also expressed LMP-1 on a limited number of the tumour cells. These cases had a significantly worse prognosis when compared with LMP-1 negative cases. 8 Histopathological studies concerning LMP-1 expression in vivo might provide more insight into the role of LMP-1 in the pathogenesis of different EBV associated diseases. However, this requires optimal detection methods including immunohistochemistry. In this respect our data show that both S12 and CS1-4 detect specific, yet distinct, LMP-1 associated signals, although S12 detected more EBV positive cells and gave stronger signals than CS1-4. Therefore, we recommend S12 for the detection of LMP-1 in tissue sections.
